BRIEF published on 07/29/2025 at 11:05, 1 year 1 month ago Meliodays and Celanese Collaborate on Hormone-Free IUD for Menstrual Pain Hormone-Free IUD Menstrual Pain Relief Meliodays VitalDose Platform Celanese Partnership
BRIEF published on 07/29/2025 at 11:05, 1 year 1 month ago Meliodays et Celanese collaborent sur un stérilet sans hormones pour les douleurs menstruelles Meliodays DIU Sans Hormones Soulagement Des Douleurs Menstruelles Plateforme VitalDose Partenariat Celanese
PRESS RELEASE published on 07/29/2025 at 11:00, 1 year 1 month ago Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain Meliodays Medical partners with Celanese to develop hormone-free non-contraceptive IUD for menstrual pain relief using VitalDose(R) Drug Delivery Platform Celanese Drug Delivery Menstrual Pain Meliodays Medical IUD
BRIEF published on 03/20/2025 at 09:10, 1 year 5 months ago Meliodays Medical Secures Over EUR 800,000 in Pre-Seed Financing Pre-seed Financing Menstrual Pain Meliodays Medical Local Treatment Innovative Healthcare
BRIEF published on 03/20/2025 at 09:10, 1 year 5 months ago Meliodays Medical obtient un financement de pré-amorçage de plus de 800 000 euros Financement De Pré-amorçage Meliodays Medical Douleurs Menstruelles Traitement Local Soins De Santé Innovants
PRESS RELEASE published on 03/20/2025 at 09:05, 1 year 5 months ago Meliodays Medical announces the closing of a pre-seed financing round of over EUR 800,000 Meliodays Medical announces successful closure of over EUR 800,000 pre-seed financing round led by capacura GmbH, focusing on new therapy for menstrual pain with hormone-free, local treatment Financing Hormone-free Menstrual Pain Meliodays Medical Pre-seed
Published on 09/12/2026 at 02:35, 11 hours 27 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 2 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 57 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 37 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 2 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 31 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 47 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 51 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 17 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 46 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
